• 694 Citations
  • 15 h-Index
1988 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Mohamed Idris is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 694 Citations
  • 15 h-Index
  • 54 Article

Host-parasite life-histories of the diurnal vs. nocturnal chronotypes of Schistosoma mansoni: adaptive significance

Mouahid, G., Mintsa Nguema, R., Al Mashikhi, K. M., Al Yafae, S. A., Idris, M. & Moné, H., Jan 1 2019, In : Tropical Medicine and International Health.

Research output: Contribution to journalArticle

  • 1 Citation (Scopus)

    Genetic diversity and transmissibility of imported Plasmodium vivax in Qatar and three countries of origin

    Abdelraheem, M. H., Bansal, D., Idris, M., Mukhtar, M. M., Hamid, M. M. A., Imam, Z. S., Getachew, S., Sehgal, R., Kaur, H., Gadalla, A. H., Al-Hamidhi, S., Al-Hashami, Z., Al-Jabri, A., Sultan, A. A. & Babiker, H., Dec 1 2018, In : Scientific Reports. 8, 1, 8870.

    Research output: Contribution to journalArticle

  • 1 Citation (Scopus)

    Altered blood cytokines, CD4 T cells, NK and neutrophils in patients with obstructive sleep apnea

    Said, E. A., Al-Abri, M. A., Al-Saidi, I., Al-Balushi, M. S., Al-Busaidi, J. Z., Al-Reesi, I., Koh, C. Y., Hasson, S. S., Idris, M. A., Al-Jabri, A. A. & Habbal, O., Oct 1 2017, In : Immunology Letters. 190, p. 272-278 7 p.

    Research output: Contribution to journalArticle

  • 5 Citations (Scopus)

    Distribution of mutations associated with antifolate and chloroquine resistance among imported Plasmodium vivax in the State of Qatar

    Bansal, D., Acharya, A., Bharti, P. K., Abdelraheem, M. H., Elmalik, A., Abosalah, S., Khan, F. Y., ElKhalifa, M., Kaur, H., Mohapatra, P. K., Sehgal, R., Idris, M. A., Mahanta, J., Singh, N., Babiker, H. A. & Sultan, A. A., Jan 1 2017, In : American Journal of Tropical Medicine and Hygiene. 97, 6, p. 1797-1803 7 p.

    Research output: Contribution to journalArticle

  • 3 Citations (Scopus)

    Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

    Gligorov, J., Ataseven, B., Verrill, M., De Laurentiis, M., Jung, K. H., Azim, H. A., Al-Sakaff, N., Lauer, S., Shing, M., Pivot, X., Koroveshi, D., Bouzid, K., Casalnuovo, M., Cascallar, D., Korbenfeld, E. P., Bastick, P., Beith, J., Colosimo, M., Friedlander, M., Ganju, V. & 31 others, Green, M., Patterson, K., Redfern, A., Richardson, G., Ceric, T., Gordana, K., Beato, C. A., Ferrari, M., Hegg, R., Helena, V., Ismael, G. F., Lessa, A. E., Mano, M., Morelle, A., Nogueira, J. A., Timcheva, K., Tomova, A., Tsakova, M., Zlatareva-Petrova, A., Asselah, J., Assi, H., Brezden-Masley, C., Chia, S., Freedman, O., Harb, M., Joy, A. A., Kulkarni, S., Prady, C., Gaete, A. A. A., Idris, M. & the SafeHer Study Group, Sep 1 2017, In : European Journal of Cancer. 82, p. 237-246 10 p.

    Research output: Contribution to journalArticle

  • 14 Citations (Scopus)